Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Abstract Patients with an implantable cardioverter defibrillator (ICD) have an ongoing risk of sudden incapacitation that might cause harm to others while driving a car. Driving restrictions vary across different countries in Europe. The most recent recommendations for driving of ICD patients in Europe were published in 1997 and focused mainly on patients implanted for secondary prevention. In recent years there has been a vast increase in the number of patients with an ICD and in the percentage of patients implanted for primary prevention. The EHRA task force on ICD and driving was formed to reassess the risk of driving for ICD patients based on the literature available. The recommendations are summarized in the following table and are further explained in the document. Restriction for private drivingRestriction for professional drivingICD implantation for secondary preventionThree monthsPermanentICD implantation for primary preventionFour weeksPermanentAfter appropriate ICD therapyThree monthsPermanentAfter inappropriate ICD therapyUntil measures to prevent inappropriate therapy are takenPermanentAfter replacement of the ICDOne weekPermanentAfter replacement of the lead systemFour weeksPermanentPatients refusing ICD for primary preventionNo restrictionPermanentPatients refusing ICD implantation for secondary preventionSeven monthsPermanentDriving restrictions are perceived as difficult for patients and their families, and have an immediate consequence for their lifestyle. To increase the adherence to the driving restrictions, adequate discharge of education and follow-up of patients and family are pivotal. The task force members hope this document may serve as an instrument for European and national regulatory authorities to formulate uniform driving regulations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., Domanski, M., Troutman, C., Anderson, J., Johnson, G., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043399 · Cited by 6,552
Bristow, M. R., Saxon, L. A., Boehmer, J., Krueger, S., Kass, D. A., De Marco, T., Carson, P., DiCarlo, L., DeMets, D., White, B. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032423 · Cited by 5,812
Moss, A. J., Hall, W. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Klein, H., Levine, J. H., Saksena, S., Waldo, A. L., Wilber, D., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612263352601 · Cited by 4,165
A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery Disease
Buxton, A. E., Lee, K. L., Fisher, J. D., Josephson, M. E., Prystowsky, E. N., & Hafley, G. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912163412503 · Cited by 2,489
Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction
Hohnloser, S. H., Kuck, K. H., Dorian, P., Roberts, R. S., Hampton, J. R., Hatala, R., Fain, E., Gent, M., & Connolly, S. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041489 · Cited by 1,519
Prevention of Implantable-Defibrillator Shocks by Treatment with Sotalol
Pacifico, A., Hohnloser, S. H., Williams, J. H., Tao, B., Saksena, S., Henry, P. D., & Prystowsky, E. N. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906173402402 · Cited by 422
Wilkoff, B. L., Auricchio, A., Brugada, J., Cowie, M., Ellenbogen, K. A., Gillis, A. M., Hayes, D. L., Howlett, J. G., Kautzner, J., Love, C. J., et al. (2008) · Heart Rhythm · doi:10.1016/j.hrthm.2008.04.013 · Cited by 364
Self-citationWilkoff, B. L., Auricchio, A., Brugada, J., Cowie, M., Ellenbogen, K. A., Gillis, A. M., Hayes, D. L., Howlett, J. G., Kautzner, J., Love, C. J., et al. (2008) · Europace · doi:10.1093/europace/eun122 · Cited by 231
Self-citationEpstein, A. E., Miles, W. M., Benditt, D. G., Camm, A. J., Darling, E. J., Friedman, P. L., Garson, A., Harvey, J. C., Kidwell, G. A., Klein, G. J., et al. (1996) · Circulation · doi:10.1161/01.cir.94.5.1147 · Cited by 220
Research works printed but not linked: 84
- The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators, 1997, A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal sustained ventricular arrhythmias, N Engl J Med, 337, 1576, 10.1056/NEJM199711273372202 · DOI · Paper page
- Connolly, 2000, Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone, Circulation, 101, 1297, 10.1161/01.CIR.101.11.1297 · DOI · Paper page
- Kuck, 2000, Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH), Circulation, 102, 748, 10.1161/01.CIR.102.7.748 · DOI · Paper page
- Bigger, 1997, Prophylactic use of implantable cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary artery bypass graft surgery, N Engl J Med, 337, 1569, 10.1056/NEJM199711273372201 · DOI · Paper page
- Moss, 2002, Prophylactic implantation of defibrillator in patients with myocardial infarction and reduced ejection fraction, N Engl J Med, 346, 877, 10.1056/NEJMoa013474 · DOI · Paper page
- Kadish, 2004, Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy, N Engl J Med, 350, 2151, 10.1056/NEJMoa033088 · DOI · Paper page
- Hammill, 2008, National ICD Registry Annual Report 2007: review of the Registry's Second Year, data collected, and plans to add lead and pediatric ICD procedures, Heart Rhythm, 5, 1359, 10.1016/j.hrthm.2008.07.015 · DOI
- Ector, 2007, Current use of pacemakers, implantable cardioverter defibrillators, and resynchronization devices: data from the registry of the European Heart Rhythm Association, Eur Heart J, 9, I44, 10.1093/eurheartj/sum062 · DOI
- Proclemer, 2009, Impact of the main implantable cardioverter-defibrillator trials in clinical practice: data from the Italian ICD Registry for the years 2005–07, Europace, 11, 465, 10.1093/europace/eun370 · DOI
- Peinado, 2008, Spanish implantable cardioverter-defibrillator registry. Fourth official report of the Spanish society of cardiology working group on implantable cardioverter-defibrillators, Rev Esp Cardiol, 61, 1191
- Anderson, 1994, Legal and ethical aspects of driving and working in patients with an implantable cardioverter defibrillator, Am Heart J, 127, 1185, 10.1016/0002-8703(94)90108-2 · DOI
- Baker, 1970, An evaluation of the hazard created by natural death at the wheel, N Engl J Med, 283, 405, 10.1056/NEJM197008202830806 · DOI
- Berger, 2002, Reporting by physicians of impaired drivers and potentially impaired drivers. The Committee on Bioethical Issues of the Medical Society of the State of New York, J Gen Intern Med, 15, 667, 10.1046/j.1525-1497.2000.04309.x · DOI
- Binns, 2000, Driving and arrhythmias, BMJ, 324, 927, 10.1136/bmj.324.7343.927 · DOI
- Grubb, 2007, Driving and implantable cardioverter-defibrillator; a clearer view, J Am Coll Cardiol, 50, 2241, 10.1016/j.jacc.2007.08.037 · DOI
- Bleakley, 2003, Driving and arrhythmias: implications of new data, Card Electrophysiol Rev, 7, 77, 10.1023/A:1023655410200 · DOI
- Blitzer, 2003, Causes of impaired consciousness while driving a motorized vehicle, Am J Cardiol, 91, 1373, 10.1016/S0002-9149(03)00336-9 · DOI
- Christian, 1988, Incidence and implications of natural deaths of road users, BMJ, 297, 1021, 10.1136/bmj.297.6655.1021 · DOI
- Finch, 1993, Driving safety among patients with automatic implantable cardioverter defibrillators, JAMA, 270, 1587, 10.1001/jama.1993.03510130093037 · DOI
- Craney, 1995, Factors related to driving in persons with an implantable cardioverter defibrillator, Prog Cardiovasc Nurs, 10, 12
- Jung, 1996, European policy on driving for patients with implantable cardioverter defibrillators, Pacing Clin Electrophysiol, 19, 981, 10.1111/j.1540-8159.1996.tb03396.x · DOI
- Jung, 1996, Quality of life and driving in recipients of the implantable cardioverter-defibrillator, Am J Cardiol, 78, 51, 10.1016/S0002-9149(96)00502-4 · DOI
- Smith, 2001, Driving after ventricular arrhythmias, N Engl J Med, 345, 451, 10.1056/NEJM200108093450609 · DOI
- Gimbel, 2004, When should patients be allowed to drive after ICD implantation?, Cleve Clin J Med, 71, 125, 10.3949/ccjm.71.2.125 · DOI
- Hartenbaum, 2005, What are the current guidelines on the use of implantable defibrillators in transportation safety critical work?, J Occup Environ Med, 47, 752
- Assessment of the cardiac patient for fitness to drive., 1992, Can J Cardiol, 8, 406
- Assessment of the cardiac patient for fitness to drive: 1996 update., 1996, Can J Cardiol, 12, 1164
- Jung, 1996, Driving and the implantable cardioverter defibrillator. Study Group on ICD and Driving, Lancet, 348, 687, 10.1016/S0140-6736(05)65114-8 · doi:10.1016/s0140-6736(05)65114-8
- Jung, 1997, Study Group on ‘ICD and Driving’ of the Working Groups on Cardiac Pacing and Arrhythmias of the European Society of Cardiology, Eur Heart J, 18, 1210, 10.1093/oxfordjournals.eurheartj.a015432 · DOI · Paper page
- Petch, 1998, Driving and heart disease, Eur Heart J, 19, 1165
- Simpson, 2007, Can J Cardiol, 1313
- Epstein, 2007, A Scientific Statement from the American Heart Association and the Heart Rhythm Society, Circulation, 115, 1170, 10.1161/CIRCULATIONAHA.106.180203 · DOI · Paper page
- Sears, 1999, Examining the psychosocial impact of implantable cardioverter defibrillators: a literature review, Clin Cardiol, 22, 481, 10.1002/clc.4960220709 · DOI · Paper page
- Finch, 1993, Driving safety among patients with automatic implantable cardioverter defibrillators, JAMA, 270, 1587, 10.1001/jama.1993.03510130093037 · DOI
- Dunbar, 2005, Psychosocial issues of patients with implantable cardioverter defibrillators, Am J Crit Care, 14, 294, 10.4037/ajcc2005.14.4.294 · DOI
- Carroll, 2008, Long-term effects of implanted cardioverter-defibrillators on health status, quality of life, and psychological state, Am J Crit Care, 17, 222, 10.4037/ajcc2008.17.3.222 · DOI
- James, 2001, The experiences of ICD patients and their partners with regards to adjusting to an imposed driving ban: a qualitative study, Coronary Health Care, 5, 80, 10.1054/chec.2001.0124 · DOI
- Eckert, 2002, How does an implantable cardioverter defibrillator (ICD) affect the lives of patients and their families?, Intern J Nursing Practice, 8, 152, 10.1046/j.1440-172X.2002.00357.x · DOI · Paper page
- Fridlund, 2000, Patients with implantable cardioverter-defibrillators and their conceptions of the life situation: a qualitative analysis, J Clin Nursing, 9, 37, 10.1046/j.1365-2702.2000.00335.x · DOI
- Craney, 1995, Factors related to driving in persons with an implantable cardioverter defibrillator, Progr Cardiovasc Nursing, 10, 12
- Kelly, 1999, Medical restrictions to driving: the awareness of patients and doctors, Postgrad Med J, 75, 537, 10.1136/pgmj.75.887.537 · doi:10.1136/pgmj.75.887.537
- Conti, 1997, Modification of patient driving behavior after implantation of a cardioverter defibrillator, Pacing Clin Electrophysiol, 20, 2200, 10.1111/j.1540-8159.1997.tb04237.x · DOI · Paper page
- Trappe, 1998, Should patients with implantable cardioverter-defibrillators be allowed to drive? Observations in 291 patients from a single center over an 11-year period, J Interv Card Electrophysiol, 2, 193, 10.1023/A:1009763818159 · DOI
- Maas, 2003, Syncope, driving recommendations, and clinical reality: survey of patients, BMJ, 326, 21, 10.1136/bmj.326.7379.21 · DOI · Paper page
- Hickey, 2001, Baseline factors predicting early resumption of driving after life-threatening arrhythmias in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial, Am Heart J, 142, 99, 10.1067/mhj.2001.115787 · DOI
- Ostrom, 1987, Natural death while driving, J Forensic Sci, 32, 988, 10.1520/JFS12410J · DOI
- Hossack, 1974, Death at the wheel. A consideration of cardiovascular disease as a contributory factor to road accidents, Med J Aust, I, 164, 10.5694/j.1326-5377.1974.tb50782.x · DOI
- Parsons, 1986, Fits and other causes of loss of consciousness while driving, Q J Med, 58, 295, 10.1093/oxfordjournals.qjmed.a067959 · DOI
- Antecol, 1990, Sudden death behind the wheel from natural disease in drivers of four wheeled motor vehicles, Am J Cardiol, 66, 1329, 10.1016/0002-9149(90)91163-Z · DOI
- Ontario Ministry of Transportation., 1987, Ontario Road Safety Annual Report
- Freedberg, 2001, Recurrence of symptomatic ventricular arrhythmias in patients with implantable cardioverter defibrillator after the first device therapy: implications for antiarrhythmic therapy and driving restrictions. CARE Group, J Am Coll Card, 37, 1910, 10.1016/S0735-1097(01)01226-8 · DOI
- Levine, 1991, Predictors of first discharge and subsequent survival in patients with automatic implantable cardioverter-defibrillators, Circulation, 84, 558, 10.1161/01.CIR.84.2.558 · DOI
- Grimm, 1993, Symptoms and electrocardiographically documented rhythm preceding spontaneous shocks in patients with implantable cardioverter-defibrillator, Am J Cardiol, 71, 1415, 10.1016/0002-9149(93)90602-9 · DOI
- Curtis, 1992, Time to first pulse after automatic implantable cardioverter defibrillator implantation, Ann Thorac Surg, 53, 984, 10.1016/0003-4975(92)90371-A · DOI
- Bansch, 1998, Syncope in patients with an implantable cardioverter-defibrillator: incidence, prediction and implications for driving restrictions, J Am Coll Cardiol, 31, 608, 10.1016/S0735-1097(97)00543-3 · DOI
- Tchou, 1991, When is it safe not to replace an implantable cardioverter defibrillator generator?, Pacing Clin Electrophysiol, 14, 1875, 10.1111/j.1540-8159.1991.tb02783.x · DOI
- Fogoros, 1989, Actuarial incidence and pattern of occurrence of shocks following implantation of the automatic implantable cardioverter defibrillator, Pacing Clin Electrophysiol, 12, 1465, 10.1111/j.1540-8159.1989.tb06151.x · DOI
- Lubinski, 2008, Potentially syncopal arrhythmias in ICD secondary prevention patients, Europace, 10, 233
- Kou, 1991, Incidence of loss of consciousness during automatic implantable cardioverter-defibrillator shocks, Ann Int Med, 115, 942, 10.7326/0003-4819-115-12-942 · DOI
- Freedberg, 2001, Recurrence of symptomatic ventricular arrhythmias in patients with implantable cardioverter defibrillator after the first device therapy: implications for antiarrhythmic therapy and driving restrictions. CARE Group, J Am Coll Cardiol, 37, 1910, 10.1016/S0735-1097(01)01226-8 · DOI
- Lerecouvreux, 2005, Automobile driving and implantable defibrillators, Arch Mal Coeur Vaiss, 98, 288
- Abello, 2006, Syncope following cardioverter defibrillator implantation in patients with spontaneous syncopal monomorphic ventricular tachycardia, Eur Heart J, 27, 89, 10.1093/eurheartj/ehi500 · DOI
- Conti, 1997, Modification of patient driving behavior after implantation of a cardioverter defibrillator, Pacing Clin Electrophysiol, 20, 2200, 10.1111/j.1540-8159.1997.tb04237.x · DOI · Paper page
- Curtis, 1995, Motor vehicle accidents in patients with an implantable cardioverter-defibrillator, J Am Coll Cardiol, 26, 180, 10.1016/0735-1097(95)00133-K · DOI · Paper page
- Alsheikh-Ali, 2008, Time-dependence of appropriate implantable defibrillator therapy in patients with ischemic cardiomyopathy, J Cardiovasc Electrophysiol, 19, 784, 10.1111/j.1540-8167.2008.01111.x · DOI · Paper page
- Raviele, 1995, Italian multicenter clinical experience with endocardial defibrillation: acute and long-term results in 307 patients, Pacing Clin Electrophysiol, 18, 599, 10.1111/j.1540-8159.1995.tb02570.x · doi:10.1111/j.1540-8159.1995.tb02570.x
- Gold, 1997, Complications associated with pectoral implantation of cardioverter defibrillators, Pacing Clin Electrophysiol, 20, 208, 10.1111/j.1540-8159.1997.tb04844.x · DOI
- Fahy, 1995, Low incidence of lead related complications associated with nonthoracotomy implantable cardioverter defibrillator systems, Pacing Clin Electrophysiol, 18, 172, 10.1111/j.1540-8159.1995.tb02499.x · doi:10.1111/j.1540-8159.1995.tb02499.x
- Danik, 2008, Jude Riata lead: a single-center experience and a review of the literature, Heart Rhythm, 5, 1667, 10.1016/j.hrthm.2008.09.017 · doi:10.1016/j.hrthm.2008.09.017
- Ebstein, 2009, Performance of the St. Jude Medical Riata Leads, Heart Rhythm, 6, 204, 10.1016/j.hrthm.2008.10.030 · DOI
- Moss, 2004, Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator, Circulation, 110, 3760, 10.1161/01.CIR.0000150390.04704.B7 · DOI · Paper page
- Sesselberg, 2007, Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: A MADIT-II substudy, Heart Rhythm, 4, 1395, 10.1016/j.hrthm.2007.07.013 · DOI · Paper page
- Poole, 2008, Prognostic importance of defibrillator shocks in patients with heart failure, N Engl J Med, 359, 1009, 10.1056/NEJMoa071098 · DOI · Paper page
- Singh, 2005, Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation, J Am Coll Cardiol, 46, 1712, 10.1016/j.jacc.2005.05.088 · DOI · Paper page
- Daubert, 2008, Inappropriate implantable cardioverter-defibrillator shocks in MADIT II. Frequency, mechanisms, predictors, and survival impact, J Am Coll Cardiol, 51, 1357, 10.1016/j.jacc.2007.09.073 · DOI · Paper page
- Klein, 2003, Analysis of implantable cardioverter defibrillator therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial, J Cardiovasc Electrophysiol, 14, 940, 10.1046/j.1540-8167.2003.01554.x · DOI · Paper page
- Alter, 2005, Complications of implantable cardioverter defibrillator therapy in 440 consecutive patients, Pacing Clin Electrophysiol, 28, 926, 10.1111/j.1540-8159.2005.00195.x · DOI · Paper page
- Sweeney, 2005, Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) trial, Circulation, 111, 2898, 10.1161/CIRCULATIONAHA.104.526673 · DOI · Paper page
- Lee, 2008, Effects of antiarrhythmic drugs on inappropriate shocks in patients with implantable cardioverter defibrillators, Circ J, 72, 102, 10.1253/circj.72.102 · DOI
- Tzeis, 2008, Tools and strategies for the reduction of inappropriate implantable cardioverter defibrillator shocks, Europace, 10, 1256, 10.1093/europace/eun205 · doi:10.1093/europace/eun205
- Sacher, 2006, Outcome after implantation of a Cardioverter-defibrillator in patients with Brugada syndrome, Circulation, 114, 2317, 10.1161/CIRCULATIONAHA.106.628537 · DOI · Paper page
- Vanhees, 2004, Effect of exercise training in patients with an implantable cardioverter defibrillator, Eur Heart J, 25, 1120, 10.1016/j.ehj.2004.04.034 · DOI · Paper page
- Davids, 2005, Benefits of cardiac rehabilitation in patients with implantable cardioverter-defibrillators: a patient survey, Arch Phys Med Rehabil, 86, 1924, 10.1016/j.apmr.2005.04.009 · DOI
- Fitchet, 2003, Comprehensive cardiac rehabilitation programme for implantable cardioverter-defibrillator patients: a randomised controlled trial, Heart, 89, 155, 10.1136/heart.89.2.155 · DOI · Paper page
Cited by
Priori, S. G., Blomström-Lundqvist, C., Mazzanti, A., Blom, N., Borggrefe, M., Camm, J., Elliott, P. M., Fitzsimons, D., Hatala, R., Hindricks, G., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv316 · Cited by 3,893
Self-citationDeveloped in collaboration with, European Heart Rhythm Association (EHRA), Heart Failure Association (HFA), and Heart Rhythm Society (HRS), societies, E. B. T. F., European Society of Emergency Medicine (EuSEM), European Federation of Internal Medicine (EFIM), European Union Geriatric Medicine Society (EUGMS), American Geriatrics Society (AGS), European Neurological Society (ENS), et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp298 · Cited by 2,040
Self-citation(2015) · Europace · doi:10.1093/europace/euv319 · Cited by 1,592
2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope
Shen, W.-K., Sheldon, R. S., Benditt, D. G., Cohen, M. I., Forman, D. E., Goldberger, Z. D., Grubb, B. P., Hamdan, M. H., Krahn, A. D., Link, M. S., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.03.004 · Cited by 478
Shen, W.-K., Sheldon, R. S., Benditt, D. G., Cohen, M. I., Forman, D. E., Goldberger, Z. D., Grubb, B. P., Hamdan, M. H., Krahn, A. D., Link, M. S., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000499 · Cited by 438
Metadata
- Authors
- Task force members, Vijgen, J., Botto, G., Camm, J., Hoijer, C.-J., Jung, W., Le Heuzey, J.-Y., Lubinski, A., Norekval, T. M., Santomauro, M., Schalij, M., Schmid, J.-P., & Vardas, P.
- Venue
- Europace
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-06-13
- Volume
- 11
- Issue
- 8
- Pages
- 1097-1107
- ISSN
- 1099-5129 (ISSN-L)
- 1532-2092
- OpenAlex
- W2153523473
- Cited by
- 98
- References
- 16
- FWCI
- 4.94
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators. https://app.cochat.ai/papers/10.1093/europace/eup112
- The paper
- Task force members, Vijgen, J., Botto, G., Camm, J., Hoijer, C.-J., Jung, W., Le Heuzey, J.-Y., Lubinski, A., Norekval, T. M., Santomauro, M., Schalij, M., Schmid, J.-P., & Vardas, P. (2009). Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators. Europace. https://doi.org/10.1093/europace/eup112
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.